Clenbuterol 0,02mg Calvin Scott

£36.00

Clenbuterol 0.02mg Calvin Scott is a beta-2 adrenergic agonist for laboratory research into thermogenic pathways and metabolic mechanisms. Precision-manufactured tablets for controlled experimental protocols.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Clenbuterol 0,02mg Calvin Scott
Clenbuterol 0,02mg Calvin Scott
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Clenbuterol 0.02mg Calvin Scott

Clenbuterol 0.02mg Calvin Scott is a beta-2 adrenergic receptor agonist compound extensively studied in metabolic research laboratories worldwide. This precision-manufactured research chemical enables scientists to investigate thermogenic pathways and adrenergic receptor mechanisms through controlled experimental protocols. Each tablet contains exactly 0.02mg of active compound, providing researchers with consistent dosing for reproducible study outcomes across various investigative frameworks.

The Calvin Scott formulation represents a pharmaceutical-grade research tool designed for in-vitro applications examining beta-adrenergic signalling cascades. Laboratory teams at Stroid UK Shop utilise this compound to study receptor binding affinity and downstream metabolic effects in cellular models. Research applications span cardiovascular physiology studies, thermogenesis investigations, and comparative analysis with other compounds available in our fat burning research collection.

Laboratory Applications and Research Protocols

Scientific investigations commonly examine clenbuterol’s interactions with beta-2 adrenergic receptors in various tissue models. Researchers evaluate thermogenic responses, lipolytic mechanisms, and protein synthesis pathways through controlled experimental designs. The precise 0.02mg tablet format facilitates accurate measurement protocols essential for peer-reviewed research publications. Studies often compare results with other research chemicals including selective androgen receptor modulators and research peptides to establish comprehensive metabolic profiles.

Laboratory protocols investigate dose-response relationships, receptor occupancy studies, and temporal analysis of biological effects. Research teams examine cellular uptake mechanisms, metabolite formation, and clearance pathways through sophisticated analytical techniques including mass spectrometry and receptor binding assays.

Technical Specifications

Clenbuterol 0.02mg Calvin Scott Research Specifications
Parameter Specification
Active Ingredient Clenbuterol Hydrochloride
Concentration 0.02mg per tablet
Molecular Formula C12H18Cl2N2O
Molecular Weight 277.19 g/mol
CAS Number 21898-19-1
Storage Cool, dry conditions
Manufacturer Calvin Scott

Research Compliance and Laboratory Use

This product is manufactured exclusively for in-vitro research applications and scientific investigation purposes. Not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must possess appropriate laboratory credentials and follow institutional safety protocols when handling this research chemical. All studies should be conducted under appropriate ethical oversight and regulatory compliance frameworks.

Related